November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Hossam El Benawi on Impact of Timing of Atrial Fibrillation Ablation
Nov 5, 2025, 10:10

Hossam El Benawi on Impact of Timing of Atrial Fibrillation Ablation

Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:

”’Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF”:

Using TriNetX (2010–2024), we studied HF patients with AF (after HF onset)undergoing early (≤1 yr) vs delayed (1–3 yrs) ablation, (7654 HFrEF, 3033 HFpEF ):

  • Delayed ablation was linked to higher AF recurrence in both HFpEF and HFrEF.
  • In HFrEF, delayed ablation →
    ↑ Redo ablation, ↑ DCCV , ↑ AAD use
  • HFpEF, delayed ablation →
    Redo ablation and DCCV, but↑ AAD use
  • No significant differences in:
    Stroke, HF hospitalizations, All-cause hospitalizations, Mortality between early vs delayed ablation in both groups.

Study link.”

Read the full article here.

Article: Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF

Authors: Mahmoud Eisa, Hossam Elbenawi, Momina Iftikhar, Ahmed El Shaer, Muhammad Eltony, Omar Almaadawy, Amro Aglan, Mahmoud Samy Ahmed, Kareem A. Mohamed, Khaled Elfert, Mahmoud Shadi, Mohan Rao, Justin Z. Lee, Zain Ul Abideen Asad, Freddy Del-Carpio Munoz, Konstantinos C. Siontis, Mark S. Link, Abhishek J. Deshmukh, Christopher V. DeSimone

Hossam El Benawi on Impact of Timing of Atrial Fibrillation Ablation

Stay updated on all scientific advances with Hemostasis Today.